XML 80 R52.htm IDEA: XBRL DOCUMENT v3.19.1
Principal Risk (Tables)
12 Months Ended
Dec. 31, 2018
Risks and Uncertainties [Abstract]  
Schedule of analyses the Group's concentration of equity price risk by country and region, and industry
  

December 31,

2018

  

December 31,

2017

 
Country and Region        
United States of America  $8,224,771   $10,462,483 
Total  $8,224,771   $10,462,483 
           
Industry          
Pharmaceutical and biotechnology  $8,224,285   $10,443,175 
Healthcare   486    19,308 
Total  $8,224,771   $10,462,483